Recombinant SURF4 Antibody and 2 more items

The University of Virginia awarded contract A207_PO-0448589 to Quartzy on June 13, 2026, for a cumulative contract value of $583. The prime contractor will deliver three specialized research materials to Samir Zuberi at the University of Virginia. The line items include DNase I Set (1 Unit/microliter, liquid formulation) at $50.56 per unit, Recombinant SURF4 Antibody at $244.40 per unit, and Galactosyl Cholesterol at $288.78 per milligram. All items are ordered in single quantities except where unit pricing reflects per-milligram measurement.

The contract represents a procurement of laboratory reagents and biological materials to support the University of Virginia's research operations. The deliverables are consistent with molecular biology and immunological research applications, with all materials designated for delivery to the same recipient within the institution. No specific performance period is identified in the available contract documentation, though the award date establishes June 13, 2026, as the contract commencement.